Targeting Mutated p53 Dependency in Triple-Negative Breast Cancer Cells Through CDK7 Inhibition

BACKGROUND: Cyclin-dependent kinase 7 (CDK7) is crucial for cell cycle progression and gene expression transcriptional regulation, which are often not assessed in cancer developing process. CDK7 inhibitors have emerged as promising drugs for treating diverse cancers, including breast cancer. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jingyu, Yang, Ming, Bi, Ran, Wang, Yueyuan, Wang, Chunxi, Wei, Xue, Zhang, Zhihao, Xie, Xiao, Wei, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183379/
https://www.ncbi.nlm.nih.gov/pubmed/34109118
http://dx.doi.org/10.3389/fonc.2021.664848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183379/
https://www.ncbi.nlm.nih.gov/pubmed/34109118
http://dx.doi.org/10.3389/fonc.2021.664848

Ejemplares similares